PD-L1
Clinical trials for PD-L1 explained in plain language.
Never miss a new study
Get alerted when new PD-L1 trials appear
Sign up with your email to follow new studies for PD-L1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to boost immune attack on hard-to-treat pancreatic cancer
Disease control Recruiting nowThis study tests whether adding low-dose radiation and an immunotherapy drug (pultelimab) to standard treatment can help control advanced pancreatic cancer. About 10 adults who have not had prior immunotherapy will receive the combination. The goal is to see if the treatment shri…
Matched conditions: PD-L1
Phase: PHASE1, PHASE2 • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New PET scan could spot cancer markers without surgery
Diagnosis Recruiting nowThis study tests a new type of PET scan (68Ga-NK224) to see if it can accurately measure PD-L1 levels in tumors without needing a biopsy. About 100 adults with cancer will get the scan, and the results will be compared to standard tissue tests. The goal is to find a less invasive…
Matched conditions: PD-L1
Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Diagnosis
Last updated May 11, 2026 20:53 UTC